Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

L-fucose utilization provides Campylobacter jejuni with a competitive advantage.

Stahl M, Friis LM, Nothaft H, Liu X, Li J, Szymanski CM, Stintzi A.

Proc Natl Acad Sci U S A. 2011 Apr 26;108(17):7194-9. doi: 10.1073/pnas.1014125108. Epub 2011 Apr 11.

2.

Campylobacter jejuni drives MyD88-independent interleukin-6 secretion via Toll-like receptor 2.

Friis LM, Keelan M, Taylor DE.

Infect Immun. 2009 Apr;77(4):1553-60. doi: 10.1128/IAI.00707-08. Epub 2009 Jan 12.

3.

A role for the tet(O) plasmid in maintaining Campylobacter plasticity.

Friis LM, Pin C, Taylor DE, Pearson BM, Wells JM.

Plasmid. 2007 Jan;57(1):18-28. Epub 2006 Aug 28.

PMID:
16934869
4.

In vitro cell culture methods for investigating Campylobacter invasion mechanisms.

Friis LM, Pin C, Pearson BM, Wells JM.

J Microbiol Methods. 2005 May;61(2):145-60. Review. Erratum in: J Microbiol Methods. 2005 Oct;63(1):104.

PMID:
15722140
5.

Nucleotide sequences and comparison of two large conjugative plasmids from different Campylobacter species.

Batchelor RA, Pearson BM, Friis LM, Guerry P, Wells JM.

Microbiology. 2004 Oct;150(Pt 10):3507-17.

PMID:
15470128
6.

Retargeted clostridial endopeptidases: inhibition of nociceptive neurotransmitter release in vitro, and antinociceptive activity in in vivo models of pain.

Chaddock JA, Purkiss JR, Alexander FC, Doward S, Fooks SJ, Friis LM, Hall YH, Kirby ER, Leeds N, Moulsdale HJ, Dickenson A, Green GM, Rahman W, Suzuki R, Duggan MJ, Quinn CP, Shone CC, Foster KA.

Mov Disord. 2004 Mar;19 Suppl 8:S42-7.

PMID:
15027053
7.

Inhibition of release of neurotransmitters from rat dorsal root ganglia by a novel conjugate of a Clostridium botulinum toxin A endopeptidase fragment and Erythrina cristagalli lectin.

Duggan MJ, Quinn CP, Chaddock JA, Purkiss JR, Alexander FC, Doward S, Fooks SJ, Friis LM, Hall YH, Kirby ER, Leeds N, Moulsdale HJ, Dickenson A, Green GM, Rahman W, Suzuki R, Shone CC, Foster KA.

J Biol Chem. 2002 Sep 20;277(38):34846-52. Epub 2002 Jul 8.

8.

Clostridium botulinum neurotoxins act with a wide range of potencies on SH-SY5Y human neuroblastoma cells.

Purkiss JR, Friis LM, Doward S, Quinn CP.

Neurotoxicology. 2001 Aug;22(4):447-53.

PMID:
11577803
9.

Inhibition of vesicular secretion in both neuronal and nonneuronal cells by a retargeted endopeptidase derivative of Clostridium botulinum neurotoxin type A.

Chaddock JA, Purkiss JR, Friis LM, Broadbridge JD, Duggan MJ, Fooks SJ, Shone CC, Quinn CP, Foster KA.

Infect Immun. 2000 May;68(5):2587-93.

Supplemental Content

Loading ...
Support Center